ConductScience.org, home

Paper25754718

Hypersensitivity to biological agents-updated diagnosis, management, and treatment.

Galvão VR and 1 other. J Allergy Clin Immunol Pract, 2015. Cited by 92 papers, by iCite.

Cite this record

ConductScience Library. Hypersensitivity to biological agents-updated diagnosis, management, and treatment. Papers, record 25754718. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25754718

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hypersensitivity to biological agents-updated diagnosis, management, and treatment.
PubMed
Journal
J Allergy Clin Immunol Pract
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
92
iCite
Relative citation ratio, by iCite
3.82
iCite
Revised in PubMed
2022-04-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Galvão VRVioleta Régnier
2Castells MCMariana C

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biological FactorsMajor topic
Drug HypersensitivityMajor topic
Desensitization, Immunologic
Humans

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.

PMIDTitleJournalYearIn PapersSource
42755765Clinical phenotypes, endotypes, and biomarker profiles of immediate rituximab hypersensitivity reactions: a prospective pharmacovigilance study.Front Allergy2026https://conductscience.org/library/papers/42755765PubMed
42677058Anifrolumab for rituximab-induced SCLE and cryoglobulinemic vasculitis in primary Sjögren's disease: a case report.Front Pharmacol2026https://conductscience.org/library/papers/42677058PubMed
42583107Safety signals for drug-related respiratory depression: a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS).J Thorac Dis2026https://conductscience.org/library/papers/42583107PubMed
41937341Immediate and delayed hypersensitivity to biologicals in children-A practical approach: An EAACI task force report.Pediatr Allergy Immunol2026https://conductscience.org/library/papers/41937341PubMed
41634892Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.J Pharm Health Care Sci2026https://conductscience.org/library/papers/41634892PubMed
40051429Allergy to ustekinumab: Validating skin tests for diagnostic and therapeutic decision-making.Asia Pac Allergy2025https://conductscience.org/library/papers/40051429PubMed
40051428Effective desensitization in an IgE-mediated hypersensitivity reaction to tocilizumab in neuromyelitis optica.Asia Pac Allergy2025https://conductscience.org/library/papers/40051428PubMed
39961769The impact of repeated drug desensitisation on quality of life in drug hypersensitivity.Clin Transl Allergy2025https://conductscience.org/library/papers/39961769PubMed
39816201Multiple Successful Desensitizations to Brentuximab Vedotin in the Setting of Relapsed Peripheral T-Cell Lymphoma: Case Report.Can J Hosp Pharm2025https://conductscience.org/library/papers/39816201PubMed
39630768Conclusions of clinical trials assessing monoclonal antibodies and sponsored by pharmaceutical industry: a meta-research study.Rev Assoc Med Bras (1992)2024https://conductscience.org/library/papers/39630768PubMed
39434186Retrospective analysis of rapid drug desensitization with biologic agents: A single center experience.Clin Transl Allergy2024https://conductscience.org/library/papers/39434186PubMed
39001293Basophil Activation Test Predicts Cetuximab Anaphylaxis Severity in Alpha-Gal IgE-Positive Patients.Diagnostics (Basel)2024https://conductscience.org/library/papers/39001293PubMed
37404435
A Case of VEXAS: Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic Syndrome With Co-existing DNA (Cytosine-5)-Methyltransferase 3A Mutation Complicated by Localized Skin Reaction to Tocilizumab and Azacitidine.
Cureus2023https://conductscience.org/library/papers/37404435PubMed
36911456Successful Rapid Desensitization of a Pediatric Multiple Sclerosis Patient with Anaphylaxis to Ocrelizumab.Ann Indian Acad Neurol2022https://conductscience.org/library/papers/36911456PubMed
36160076Successful Rapid Drug Desensitization with A Modified Protocol To Alemtuzumab in A Multiple Sclerosis Patient with Severe Immediate-Type Hypersensitivity Reaction.Noro Psikiyatr Ars2022https://conductscience.org/library/papers/36160076PubMed
35286851Mechanistic contributions of Kupffer cells and liver sinusoidal endothelial cells in nanoparticle-induced antigen-specific immune tolerance.Biomaterials2022https://conductscience.org/library/papers/35286851PubMed
34939919Paradoxical Reactions to Biologicals in Chronic Inflammatory Systemic Diseases.Dtsch Arztebl Int2022https://conductscience.org/library/papers/34939919PubMed
34463914Non-IgE-Mediated Drug Hypersensitivity Reactions.Curr Allergy Asthma Rep2021https://conductscience.org/library/papers/34463914PubMed
34319562Hypersensitivity and Immune-related Adverse Events in Biologic Therapy.Clin Rev Allergy Immunol2022https://conductscience.org/library/papers/34319562PubMed
34186142Optimizing drug inhibition of IgE-mediated anaphylaxis in mice.J Allergy Clin Immunol2022https://conductscience.org/library/papers/34186142PubMed

See all 42 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25754718

GET https://conductscience.org/api/papers/v1/25754718/cited_by?page=2